SCHEMBL5505339

SCHEMBL5505339

CCOc1ccnc2ccc(/C=C3/SC(NCCc4cccc(F)c4)=NC3=O)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CISD1 Q9NZ45 1/20 0.48
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
GAA P10253 1/20 0.39
XDH P47989 1/20 0.37
ALOX5 P09917 2/20 0.36
AURKA O14965 1/20 0.34
NTRK1 P04629 1/20 0.34
CSNK2A2 P19784 2/20 0.34
CSNK2A1 P68400 1/20 0.34
HPGD P15428 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ADORA1 P30542 1/20 0.33
PIK3CD O00329 1/20 0.33
GAK O14976 1/20 0.33
RPS6KA4 O75676 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505342 1.00 CISD1 (0.48) CISD1MEN1KMT2AGAAXDH
SCHEMBL14437310 1.00 CISD1 (0.48) CISD1MEN1KMT2AGAAXDH
SCHEMBL14437296 0.91 CISD1 (0.45) CISD1MEN1KMT2AXDHALOX5
SCHEMBL14437295 0.90 CISD1 (0.45) CISD1MEN1KMT2AXDHALOX5
SCHEMBL5505672 0.88 CISD1 (0.46) CISD1MEN1KMT2AGAAXDH
SCHEMBL14452267 0.88 CISD1 (0.46) CISD1MEN1KMT2AGAAXDH
SCHEMBL5505668 0.88 CISD1 (0.46) CISD1MEN1KMT2AGAAXDH
SCHEMBL3864349 0.87 CISD1 (0.48) CISD1MEN1KMT2AGAAXDH
SCHEMBL3864350 0.87 CISD1 (0.48) CISD1MEN1KMT2AGAAXDH
SCHEMBL3868935 0.87 CISD1 (0.48) CISD1MEN1KMT2AGAAXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253285-B2 Thiazolinone 4-monosubstituted quinolines HOFFMANN-LA ROCHE INC. (US) 2007-08-07 US disclosed
EP-1797085-A1 THIAZOLINONE 4-MONOSUBSTITUTED QUINOLINES F. Hoffmann-Roche AG (CH) 2007-06-20 EP disclosed
US-20060063805-A1 Thiazolinone 4-monosubstituted quinolines CHEN LI 2006-03-23 US disclosed
WO-2006029861-A1 THIAZOLINONE 4-MONOSUBSTITUTED QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063805-A1 Thiazolinone 4-monosubstituted quinolines CDK1, CDK14, CDK17 CISD1 905/4885MEN1 1239/4885KMT2A 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.